Patrick M. Woster currently serves as Professor, Chair and SmartState Endowed Chair in Drug Discovery at the Medical University of South Carolina. Dr. Woster received a B.S. in Pharmacy in 1978 and a Ph.D. in Medicinal Chemistry in 1987, both from the University of Nebraska Medical Center. He was a postdoctoral associate in Chemistry at Rensselaer Polytechnic Institute and in Medicinal Chemistry at the University of Michigan, mentored by James K. Coward. Dr. Woster has conducted research in multiple areas, including the discovery of inhibitors of the polyamine pathway, novel antitumor compounds and epigenetic modulators. He is perhaps best known for the 1996 discovery (in collaboration with David Edwards) of 6,7-dihydroxybergamottin, the constituent in grapefruit juice that inhibits cytochrome P450 in the gut, altering the bioavailability of numerous therapeutic agents. In collaboration with Robert A. Casero, Jr., he synthesized small-molecule inhibitors of the histone demethylase lysine-specific demethylase 1 that promote the re-expression of tumor suppressor factors. He has authored more than 145 manuscripts, holds 13 patents and has given numerous invited presentations. Dr. Woster is a Fellow of the American Chemical Society (2014), the Royal Society of Chemistry (2015), the Asian Federation of Medicinal Chemistry (2017), and the American Association for the Advancement of Science (2017). In 2019, he was inducted into the ACS Division of Medicinal Chemistry Hall of Fame.